SEARCH

SEARCH BY CITATION

References

  • 1
    Varis K Diabetic gastroparesis. Scand J Gastroenterol 1989; 11: 897903.
  • 2
    Loo FD, Palmer DW, Soergel KH, Kalbfleish JH, Wood CM. Gastric emptying in patients with diabetes mellitus. Gastroenterology 1984; 11: 48594.
  • 3
    Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJC. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985; 11: 19.
  • 4
    Keshavarzian A, Iber FL, Vaeth J Gastric emptying with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987; 11: 2935.
  • 5
    Iber FL, Parveen S, Van Drunen M, et al. Relation of symptoms to impaired stomach, small bowel and colon motility in long-standing diabetes. Dig Dis Sci 1993; 11: 4551.
  • 6
    Smout AJPM, Jebbink HJA, Bravenboer B Gastrointestinal manifestations of diabetic neuropathy. Neth J Med 1991; 11: 32932.
  • 7
    Horowitz M Disordered gastric motor function in diabetes mellitus. Scand J Gastroenterol 1991; 11: 67384.
  • 8
    Malagelada JR, Rees WDW, Mazzotta LJ, Go VLW Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanecol. Gastroenterology 1980; 11: 28693.
  • 9
    Snape WJ, Battle WM, Schwartz SS, et al. Metoclopramide to treat gastroparesis due to diabetes mellitus. Ann Intern Med 1982; 11: 4446.
  • 10
    De Caestecker JS, Ewing DJ, Tothill P, Clarke BF, Heading RC Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: an eight-week double blind crossover study. Aliment Pharmacol Ther 1989; 11: 6981.
  • 11
    Drenth JPH & Engels LGJB. Diabetic gastroparesis. A critical reappraisal of new treatment strategies. Drugs 1992; 11: 53753.
  • 12
    Peeters TL, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 11: G4704.
  • 13
    Depoortere I, Peeters TL, Matthijs G, et al. Structure–activity relation of erythromycin-related macrolides in inducing contractions and in displacing bound motilin in rabbit duodenum. J Gastrointest Mot 1989; 11: 1509.
  • 14
    Depoortere I, Peeters TL, Vantrappen G The erythromycin derivative EM-523 is a potent motilin agonist in man and rabbit. Peptides 1990; 11: 5159.
  • 15
    Zara GP, Thompson HH, Pilot MA, et al. Effects of erythromycin on gastrointestinal tract motility. J Antimicrob Chemother 1985; 11: 1759.
  • 16
    Tack J, Janssens J, Vantrappen G, et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992; 11: 729.
  • 17
    Annese V, Jannsens J, Vantrappen G, Willemse P, Peeters T Erythromycin accelerates gastric emtying by the induction of power contractions and improved antroduodenal coordination. Gastroenterology 1992; 11: 82531.
  • 18
    Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 1990; 322: 1028–31.
  • 19
    Peeters TL Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 11: 18869.
  • 20
    Farrugia G, Camilleri M, Whitehead WE Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am 1996; 11: 22546.
  • 21
    Catnach SM & Fairclough PD Erythromycin and the gut. Gut 1992; 11: 397401.
  • 22
    Richards RD, Davenport KG, McCallum RW The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 11: 2037.
  • 23
    Wadhwa NK, Atkins H, Cabralda T Intraperitoneal erythromycin for gastroparesis. Ann Intern Med 1991; 11: 912.
  • 24
    Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 11: 18991907.
  • 25
    Fraser RJ, Horowitz M, Maddox AF, Dent J Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis—effects of cisapride. Gut 1994; 11: 1728.
  • 26
    Corinaldesi R, Stanghellini V, Raiti C, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with diabetic gastroparesis. Gut 1987; 11: 3005.
  • 27
    Annese V, Caruso N, Accadia L, et al. Gallbladder function and gastric liquid emptying in achalasia. Dig Dis Sci 1991; 11: 111620.
  • 28
    Annese V, Bassotti G, Napolitano G, et al. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol 1995; 11: 27982.
  • 29
    Elashoff JD, Ready TJ, Meyer JH Analysis of gastric emptying data. Gastroenterology 1982; 11: 130612.
  • 30
    Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 11: 67580.
  • 31
    DeFronzo RA, Tobin JD, Andres R Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1978; 11: E21423.
  • 32
    Perkel MS, Hrsh T, Moore C, Davidson ED Metoclopramide therapy in fifty-five patients with delayed gastric emptying. Am J Gastroenterol 1980; 11: 2316.
  • 33
    Saltzman MB & McCallum RW Diabetes and the stomach. Yale J Biol Med 1983; 11: 17987.
  • 34
    Ricci DA, Saltzman MB, Meyer C, Callachan C, McCallum RW Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol 1985; 11: 2532.
  • 35
    Gwee KA & Read NW Rolling review: disorders of gastrointestinal motility—therapeutic potentials and limitations. Aliment Pharmacol Ther 1994; 11: 10518.
  • 36
    Schade RR, Dugas MC, Lhotsky DM, Gavaler JS, Van Thiel DH Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 11: 105.
  • 37
    McCallum RW Review of the current status of prokinetic agents in gastroenterology. Am J Gastroenterol 1985; 11: 100816.
  • 38
    Wiseman LR & Fauld D Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 11: 11652.
  • 39
    Havelund T, Oster-Jorgensen E, Eshoj O, Lytken Larsen M, Lauritsen K Effect of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus: a double-blind controlled trial. Acta Med Scand 1987; 11: 33943.
  • 40
    Weber FH, Richards RD, McCallum RW Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol 1993; 11: 48590.
  • 41
    Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K Erythromycic mimics exogenous motilin in gastrointestinal contractile activity in the gut. Am J Physiol 1984; 11: G68894.
  • 42
    Zara GP, Qin XY, Pilot MA, Thompson H, Maskell J Response of the human gastrointestinal tract to erythromycin. J Gastrointest Mot 1991; 11: 2631.
  • 43
    Mosewecz H, Pavel D, Pitrak D, et al. Erythromycin stearate as a prokinetic agent in postvagotomy gastroparesis. Dig Dis Sci 1990; 11: 9025.
  • 44
    Camilleri M The current role of erythromycin in the clinical management of gastric emptying disorders. Am J Gastroenterol 1993; 11: 16971.
  • 45
    Bruley des Varannes S, Ropert A, Parys V, Rozè C, Galmiche JP Erythromycin decreases the duration of postprandial fundic relaxation in humans. Gastroenterology 1993; 11: A484 (Abstract).
  • 46
    Freaser R, Shearer T, Fuller J, Horowitz M, Dent J Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric and duodenal motility. Gastroenterology 1992; 11: 1149.
  • 47
    Desautels SG, Hutson WR, Christian PE, Moore JG, Datz FL Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Dig Dis Sci 1995; 11: 1416.